Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01378975
What this trial is testing

Vemurafenib in Metastatic Melanoma Participants With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 146
Testing effectiveness (Phase 2)Study completedNCT00563823
What this trial is testing

Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Cambridge University Hospitals NHS Foundation Trust 34
Early research (Phase 1)Study completedNCT02858869
What this trial is testing

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more
Emory University 25
Testing effectiveness (Phase 2)Ended earlyNCT00671554
What this trial is testing

Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma

Who this might be right for
Melanoma
Prisma Health-Upstate 3
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Ended earlyNCT01308294
What this trial is testing

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05912244
What this trial is testing

IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT01827111
What this trial is testing

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00436930
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Hoag Memorial Hospital Presbyterian 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02965716
What this trial is testing

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Advanced MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+5 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00002973
What this trial is testing

Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 34
Not applicableStudy completedNCT02133222
What this trial is testing

Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

Who this might be right for
Metastatic (Stage IV) Melanoma
Centre Hospitalier Universitaire de Nice 22
Testing effectiveness (Phase 2)Study completedNCT00002786
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00066196
What this trial is testing

Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Metastatic Melanoma
MedImmune LLC 110
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00256282
What this trial is testing

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Melanoma
John P. Fruehauf 52
Testing effectiveness (Phase 2)Study completedNCT00003339
What this trial is testing

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 48
Testing effectiveness (Phase 2)Study completedNCT00003802
What this trial is testing

Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Very early researchEnded earlyNCT02591654
What this trial is testing

MRI and PET to Assess Pembrolizumab Response

Who this might be right for
Malignant Melanoma, Metastatic
Columbia University 6
Early research (Phase 1)Study completedNCT00104845
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 19
Next Page